Latest News

Liverpool, UK – MyCardium AI, a pioneering Healthtech company developing cutting edge AI solutions for cardiac imaging, is proud to announce that it is now an official member of AXREM, the UK trade association representing the medical imaging and radiotherapy industry. By joining AXREM, MyCardium AI reinforces its commitment to collaboration, standards, and innovation within the UK ....

We are proud to announce that 1EchoConfidence has officially received CE Class IIb certification. A major milestone that reflects our unwavering commitment to safety, quality, and innovation in healthcare technology. What does Class IIb mean? This classification is reserved for medium-to-high-risk medical devices and indicates rigorous regulatory scrutiny. CE Class IIb approval confirms that 1....

We’re thrilled to announce that our cutting-edge 1CMR Pro AI software has officially received CE Class IIb approval! This certification is a significant milestone, reinforcing our commitment to providing innovative, regulatory-approved AI solutions that enhance cardiovascular diagnostics. With CE Class IIb approval, MyCardium AI can now bring 1CMR Pro to more clinicians across Europe, help....

Prof. Charlotte Manisty joins The HealthTech Podcast to discuss the transformative role of AI in cardiac imaging. In this episode, she explores how AI-driven technologies like MyCardium AI are enhancing clinical workflows, improving diagnostics, and shaping the future of cardiovascular healthcare.

MyCardium AI can announce a significant milestone in cardiology innovation with the publication of cutting-edge research in the Journal of the American College of Cardiology (JACC). This study, led by Hunain Shiwani and supported by the expertise of Rhodri Davies from UCL, highlights the transformative potential of artificial intelligence in redefining how hypertrophic cardiomyopathy (HCM) is diag....

MyCardium AI, a leading innovator in cardiovascular imaging technology, is delighted to announce that its revolutionary AI-driven post processing analysis software for CMR (1CMR Pro) has received FDA 510(K) clearance. This significant milestone enables clinical use of the software in the US. The FDA's approval underscores the efficacy and safety of MyCardium AI's software in a clinical environmen....

We are proud to announce that MyCardium AI has officially received ISO 13485 accreditation, a prestigious certification that reflects our commitment to providing safe, effective, and high-quality AI-driven medical solutions. This certification marks a pivotal step in our journey toward reshaping the future of cardiovascular diagnostics, solidifying our place as a leader in the development of AI te....

A new guide designed to accelerate and support a new generation of innovative software spinouts has been launched by a leading group of universities, including UCL, with the advice and backing of major investors. Spinouts are companies usually formed by academics or researchers based on the intellectual property or research they developed at a university. The University Spinout Investment Term....

Cardiac MRI has helped hundreds of thousands of people with heart problems over the last 40 years. Dr Phoebe Kitscha learns more from three British Heart Foundation-funded scientists who are making progress in this area. Magnetic resonance imaging (MRI) is a type of medical scan first developed in the late 1980s. It uses a magnetic field and computer-generated radio waves to create detailed image....

Total Commitment to Data Security and Confidentiality MyCardium AI Ltd, a developer of innovative AI enhanced Cardiac Image Analysis tools and Cardiac Image Core Lab service company, is pleased to announce that it has been awarded ISO 27001 certification by BSI. This achievement underscores the company's unwavering commitment to safeguarding data privacy and security and to maintaining the highes....